Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
4.060
-0.050 (-1.22%)
Nov 25, 2025, 4:00 PM EST - Market closed

Aethlon Medical Statistics

Total Valuation

Aethlon Medical has a market cap or net worth of $3.09 million. The enterprise value is -$2.22 million.

Market Cap3.09M
Enterprise Value -2.22M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date Nov 12, 2025
Ex-Dividend Date n/a

Share Statistics

Aethlon Medical has 761,318 shares outstanding. The number of shares has increased by 191.00% in one year.

Current Share Class 761,318
Shares Outstanding 761,318
Shares Change (YoY) +191.00%
Shares Change (QoQ) +91.44%
Owned by Insiders (%) 0.58%
Owned by Institutions (%) 11.91%
Float 756,925

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.54
P/TBV Ratio 0.54
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.09.

Current Ratio 4.45
Quick Ratio 4.32
Debt / Equity 0.09
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -701.20

Financial Efficiency

Return on equity (ROE) is -191.39% and return on invested capital (ROIC) is -67.61%.

Return on Equity (ROE) -191.39%
Return on Assets (ROA) -54.79%
Return on Invested Capital (ROIC) -67.61%
Return on Capital Employed (ROCE) -119.78%
Revenue Per Employee n/a
Profits Per Employee -$1.25M
Employee Count9
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -87.45% in the last 52 weeks. The beta is 1.63, so Aethlon Medical's price volatility has been higher than the market average.

Beta (5Y) 1.63
52-Week Price Change -87.45%
50-Day Moving Average 5.87
200-Day Moving Average 19.74
Relative Strength Index (RSI) 39.95
Average Volume (20 Days) 40,689

Short Selling Information

The latest short interest is 36,998, so 4.86% of the outstanding shares have been sold short.

Short Interest 36,998
Short Previous Month 133,219
Short % of Shares Out 4.86%
Short % of Float 4.89%
Short Ratio (days to cover) 0.58

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -7.09M
Pretax Income -11.26M
Net Income -11.26M
EBITDA -6.76M
EBIT -7.09M
Earnings Per Share (EPS) -$46.60
Full Income Statement

Balance Sheet

The company has $5.85 million in cash and $542,411 in debt, giving a net cash position of $5.31 million or $6.98 per share.

Cash & Cash Equivalents 5.85M
Total Debt 542,411
Net Cash 5.31M
Net Cash Per Share $6.98
Equity (Book Value) 5.75M
Book Value Per Share 7.55
Working Capital 4.85M
Full Balance Sheet

Cash Flow

Operating Cash Flow -7.06M
Capital Expenditures n/a
Free Cash Flow -7.06M
FCF Per Share -$9.27
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Aethlon Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -191.00%
Shareholder Yield -191.00%
Earnings Yield -364.24%
FCF Yield -228.31%

Analyst Forecast

The average price target for Aethlon Medical is $287.50, which is 6,981.28% higher than the current price. The consensus rating is "Buy".

Price Target $287.50
Price Target Difference 6,981.28%
Analyst Consensus Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -47.67%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on October 20, 2025. It was a reverse split with a ratio of 1:10.

Last Split Date Oct 20, 2025
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 2